Abstract
Infective endocarditis (IE) most often results from bacterial infection, but infections caused by fungi, Coxiella, or Chlamydia are not rare. Infection usually involves heart valves not always previously known to be abnormal, in particular a bicuspid aortic valve, mitral valve prolapse, or (rarely) a septal defect or ventricular aneurysm. Coarctation of the aorta, patent ductus arteriosus, aneurysms, or arteriovenous shunts may be the site of infective endarteritis. Prosthetic valves may be involved, and infection at the site of implantation of foreign material including devices poses a particularly difficult problem.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ACC/AHA 2008: Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;52:676–85.
Bach DS. Perspectives on the American College of Cardiology/American Heart Association guidelines for the prevention of infective endocarditis. J Am Coll Cardiol. 2009;53:1852–4.
Cohen J. Antifungal chemotherapy. Lancet. 1982;2:1323.
DeSimone DC, Tleyjeh IM, de Sa Correa DD, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American heart association’s endocarditis prevention guidelines. Circulation. 2012;126:60–4.
ESC: Endorsed by the European Society of Clinical Micro, Authors/Task Force Members, Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European society of cardiology (ESC). Eur Heart J. 2009;30(19):2369–413.
Horstkotte D, Sick P, Bircks W, et al. Effectiveness of antibiotic prophylaxis to prevent prosthetic valve endocarditis: evidence in humans. J Am Coll Cardiol. 1991;71:2125.
Khan MG. Endocarditis. In: Encyclopedia of heart diseases. New York: Springer; 2011. p. 471.
MacMahon SW, Hickey AJ, Wilcken DEL, et al. Risk of infective endocarditis in mitral valve prolapse with and without precordial systolic murmurs. Am J Cardiol. 1986;58:105.
Maron BJ, Lever H. In defense of antimicrobial prophylaxis for prevention of infective endocarditis in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54(24):2339–40.
NICE Short Clinical Guidelines Technical Team. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. London: National Institute for Health and Clinical Excellence; 2008.
Punnoose AR, Lynm C, Golub RM. TOPICS: antibiotics, bacterial endocarditis. JAMA. 2012;308(9):935.
Towns ML, Reller LB. Diagnostic methods as current best practices and guidelines for isolation of bacteria and fungi in infective endocarditis. Infect Dis Clin North Am. 2002;16:363.
Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis. Guidelines from the American heart association. A guideline from the American heart association rheumatic fever, endocarditis, and Kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116:1736–54.
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 2014;129:e521–643.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Khan, M.G. (2015). Infective Endocarditis. In: Cardiac Drug Therapy. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-962-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-61779-962-4_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-961-7
Online ISBN: 978-1-61779-962-4
eBook Packages: MedicineMedicine (R0)